Recall Alert: Extended-Release Xanax (Alprazolam) Tablets - Lot 8177156
A recall has been issued for a specific lot of extended-release Xanax (alprazolam) tablets due to the drug failing to meet dissolution specifications. This recall affects 3 mg Xanax tablets provided in 60-tablet bottles. Alprazolam is a commonly prescribed benzodiazepine in the United States, and the failure to meet dissolution specifications could impact the dosage delivery over time. The recall is classified as Class II, indicating that exposure to the product may cause temporary or medically reversible adverse health consequences. The affected lot number is 8177156 with an expiration date of 02/28/2027. Viatris Inc., the pharmaceutical company behind the recall, has not provided further details on the number of pills or bottles included in the recall.